JP TSE 4577 Pharmaceutical

Daito Pharmaceutical Co., Ltd.

ダイト株式会社

Revenue

¥50.6B

≈ $320.9M

Net income

¥3.2B

≈ $20.0M

Income taxes paid

¥729M

≈ $4.6M

Total assets

¥73.3B

≈ $464.4M

Equity ratio

72.2%

Ranked #1,625 among listed Japanese companies by corporate taxes paid · effective tax rate 22.8%.

Share price at fiscal year-end: ¥1,202 · market capitalization ¥34.7B · P/E 11.2 · P/B 0.65

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
May 2026	¥50.6B	¥3.2B	¥928M	¥729M	¥73.3B	¥52.9B	72.2%	EDINET (consol.)
May 2025	¥50.6B	¥1.9B	¥1.2B	¥842M	¥78.0B	¥52.1B	66.7%	EDINET (consol.)
May 2024	¥46.9B	¥3.3B	—	—	¥77.7B	¥52.3B	67.3%	EDINET (consol.)
May 2023	¥45.1B	¥3.6B	—	—	¥70.6B	¥51.0B	72.2%	EDINET (consol.)
May 2022	¥43.5B	¥4.7B	—	—	¥64.9B	¥47.7B	73.4%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.